IL250852B - Periodontal composition - Google Patents
Periodontal compositionInfo
- Publication number
- IL250852B IL250852B IL250852A IL25085217A IL250852B IL 250852 B IL250852 B IL 250852B IL 250852 A IL250852 A IL 250852A IL 25085217 A IL25085217 A IL 25085217A IL 250852 B IL250852 B IL 250852B
- Authority
- IL
- Israel
- Prior art keywords
- periodontal
- oral cavity
- periodontal composition
- composition
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an oral delivery composition, more particularly a solid dosage form, for delivering a therapeutic agent, e.g., an antibacterial agent, to a soft tissue in the oral cavity such as a periodontal pocket so as to treat an oral cavity related disease such as periodontal disease; and to a method of use.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL250852A IL250852B (en) | 2017-02-28 | 2017-02-28 | Periodontal composition |
PCT/IL2018/050217 WO2018158763A1 (en) | 2017-02-28 | 2018-02-27 | Periodontal composition and method of use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL250852A IL250852B (en) | 2017-02-28 | 2017-02-28 | Periodontal composition |
Publications (2)
Publication Number | Publication Date |
---|---|
IL250852A0 IL250852A0 (en) | 2017-05-01 |
IL250852B true IL250852B (en) | 2018-02-28 |
Family
ID=61273968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL250852A IL250852B (en) | 2017-02-28 | 2017-02-28 | Periodontal composition |
Country Status (2)
Country | Link |
---|---|
IL (1) | IL250852B (en) |
WO (1) | WO2018158763A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019069298A2 (en) | 2018-01-18 | 2019-04-11 | Christian Arnold | Chewing gum composition comprising polyhexanide |
EP3771338A1 (en) * | 2019-07-29 | 2021-02-03 | The Procter & Gamble Company | Acidic antimicrobial composition |
EP3771337A1 (en) | 2019-07-29 | 2021-02-03 | The Procter & Gamble Company | Antimicrobial composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1317358B1 (en) * | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | CROSS-LINKATED DERIVATIVES OF HYALURONIC ACID. |
CZ28634U1 (en) * | 2015-05-05 | 2015-09-14 | Contipro Pharma A.S. | Hyaluronan and octenidine dihydrochloride-based dental composition |
CN105168238A (en) * | 2015-08-13 | 2015-12-23 | 南京天纵易康生物科技股份有限公司 | Hyaluronic temperature-sensitive gel and preparation method and application thereof |
-
2017
- 2017-02-28 IL IL250852A patent/IL250852B/en unknown
-
2018
- 2018-02-27 WO PCT/IL2018/050217 patent/WO2018158763A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2018158763A1 (en) | 2018-09-07 |
IL250852A0 (en) | 2017-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
MX2016010213A (en) | Novel pharmaceutical formulations. | |
MX2022003072A (en) | Use of pridopidine for treating functional decline. | |
MX2018009173A (en) | USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH). | |
PH12016502352A1 (en) | Pharmaceutical composition | |
TW201613578A (en) | Pharmaceutical combinations | |
MX2021002321A (en) | Novel methods. | |
MX2017004772A (en) | Compositions and methods for physiological delivery using cannabidiol. | |
MX2020011817A (en) | Methods for treating lymphoma. | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
MX2022015629A (en) | Use of vibegron to treat overactive bladder. | |
MX2021002322A (en) | Novel methods. | |
MX2018008646A (en) | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives. | |
IL250852B (en) | Periodontal composition | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
PH12019501820A1 (en) | Pharmaceutical compositions for combination therapy | |
MX2021011986A (en) | Methods of treating neuropathic pain. | |
MX2023006235A (en) | Compositions for drug delivery and methods of use thereof. | |
MX2020003697A (en) | Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof. | |
MX2018004774A (en) | Substituted morpholine derivatives having activity against pain. | |
PH12020500120A1 (en) | Pharmaceutical compositions | |
EP3829643C0 (en) | Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields | |
IN2013MU03428A (en) | ||
MX2018015240A (en) | Compositions comprising timolol and their use in the treatment of rosacea by topical administration. | |
PH12016502107A1 (en) | Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders |